"No Patent" low cost drug for Malaria proposed

A low priced drug for malaria has been produced by a paris based drug company Sanofi-Aventis. The world's fourth largest drug company has decided not to seek any patents so the pills can be freely copied by generic companies like those in India. The company proposes to sell the drug at no profit at less than $1 to very poor customers and $3 to $4 to wealthier ones. The pill is designed primarily for Africa, where a child dies of malaria every 30 seconds.